Immunobiology of African trypanosomiasis

Chemical Immunology

Volumn 70, Issue , 1998, Pages 186-199

  Sternberg, Jeremy M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN M; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROSTAGLANDIN; PROTOZOON ANTIBODY;

AFRICAN TRYPANOSOMIASIS; ANTIBODY RESPONSE; ANTIGENIC VARIATION; B LYMPHOCYTE ACTIVATION; HUMAN; IMMUNOBIOLOGY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NONHUMAN; PARASITEMIA; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SKIN MANIFESTATION; TRYPANOSOMA BRUCEI; ZOONOSIS;

EID: 0031963652     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058706     Document Type: Review

References (67)

1. Seed JR, Hall JE: Trypanosomes causing disease in man in Africa; in Kreier JP, Baker JR (eds): Parasitic Protozoa. San Diego, Academic Press, 1992, vol II, pp 85-155.
2. Godfrey DG, Baker RD, Rickman LR, Mehlitz D: The distribution, relationships and identification of enzyme variants within the subgenus Trypanozoon. Adv Parasitol 1990;29:1-74.
3. World Health Organisation: World Health Report 1996. Fighting Disease, Fostering Development. Geneva, WHO, 1996.
4. De Gee ALW, Levine RF, Mansfield JM: Genetics of resistance to African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses. J Immunol 1984;140:283-288.
5. Luckins AG, Gray AR: An extravascular site of development of Trypanosoma congolense. Nature 1978;272:613-614.
6. Luckins AG, McIntyre N, Rae PF: Multiplication of Trypanosoma evansi at the site of infection in the skin of rabbits and cattle. Acta Trop 1991;50:19-27.
7. Hamm B, Schindler A, Mecke D, Duszenko M: Differentiation of Trypanosoma brucei bloodstream trypomastigotes from long slender to short stumpy-like forms in axenic culture. Mol Biochem Parasitol 1990;40:13-22.
8. Jenni L, Rudin W, Schell KF: Extravascular and vascular distribution of Trypanosoma b. gambiense in Microtus montanus after cyclical transmission; in Van Marck EAE (ed): From Parasitic Infections to Parasitic Disease. Basel, Karger, 1983, pp 95-102.
9. Pays E, Steinert M: Control of antigen gene expression in African trypanosomes. Annu Rev Genet 1988;22:107-126.
10. Borst P: Discontinuous transcription and antigenic variation in trypanosomes. Annu Rev Biochem 1986;55:701-732.
11. Turner CMR, Barry JD: High frequency of antigenic variation in Trypanosoma brucei rhodesiense infections. Parasitology 1989;99:67-75.
12. Campbell GH, Esser KM, Weinbaum FI: Trypanosoma rhodesiense infection in B-cell-deficient mice. Infect Immun 1977;18:434-438.
13. Mansfield J: T-cell responses to the trypanosome variant surface glycoprotein: A new paradigm? Parasitol Today 1994;10:267-270.
14. Morrison WI, Murray M, Akol GWO: Immune responses of cattle in African trypanosomiasis; in Tizard I (ed): Immunology and Pathogenesis of Trypanosomiasis. Boca Raton, CRC Press, 1985, pp 103-131.
15. Murray PK, Jennings FW, Murray M, Urquhart GM: The nature of immunosuppression in Trypanosoma brucei infections in mice. Immunology 1974;27:815-824.
16. Murray PK, Jennings FW, Murray M, Urquhart GM: The nature of immunosuppression in Trypanosoma brucei infections in mice. II. The role of the T and B lymphocytes. Immunology 1974;27: 825-840.
17. Ilemobade AA, Adsegboye DS, Onoviran O, Chima JC: Immunodepressive effects of trypanosomal infection in cattle immunized against contagious bovine pleuropneumonia. Parasite Immunol 1982; 4:273-282.
18. Greenwood BM, Whittle HC, Molyneux DH: Immunosuppression in Gambian trypanosomiasis. Trans R Soc Trop Med Hyg 1973;67:846.
19. Bancroft GJ, Askonas BA: Immunobiology of African trypanosomiasis in laboratory rodents; in Tizard I (ed): Immunology and Pathogenesis of Trypanosomiasis. Boca Raton, CRC Press, 1985, pp 76-101.
20. Borowy NK, Sternberg JM, Schreiber D, Nonnengasser C, Overath P: Suppressive macrophages occurring in murine Trypanosoma brucei infection inhibit T-cell responses in vivo and in vitro. Parasite Immunol 1990;12:233-246.
21. Flynn JN, Sileghem M: The role of the macrophage in induction of immunosuppression in Trypanosoma congolense-infected cattle. Immunology 1991;74:310-316.
22. Mayor-Withey KS, Clayton CE, Roelants GE, Askonas BA: Trypanosomiasis leads to extensive proliferation of B, T and null cells in spleen and bone marrow. Clin Exp Immunol 1978;34:359-363.
23. Grosskinsky CM, Ezekowitz RAB, Berton G, Gordon S, Askonas BA: Macrophage activation in murine African trypanosomiasis. Infect Immune 1983;39:1080-1086.
24. Vray B, De Baetselier P, Ouaissi A, Carlier, Y: Trypanosoma cruzi but not Trypanosoma brucei fails to induce a chemiluminescent signal in a macrophage hybridoma cell line. Infect Immun 1991;59: 3303-3308.
25. Schleifer KW, Mansfield JM: Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J Immunol 1993;151:5492-5503.
26. Fierer J, Salmon JA, Askonas BA: African trypanosomiasis alters prostaglandin production by murine peritoneal macrophages. Clin Exp Immunol 1984;58:548-556.
27. Sternberg J, McGuigan F: Nitric oxide mediates suppression of T-cell responses in murine Trypanosoma brucei infection. Eur J Immunol 1992;22:2741-2744.
28. Van Velthuysen M-LF, Mayen AEM, Van Rooijen N, Fleuren GJ, De Heer E, Bruijn JA: T-cells and macrophages in Trypanosoma brucei-related glomerulopathy. Infect Immun 1994;62:3230-3235.
29. Phipps RP, Stein SH, Roper RL: A new view of prostaglandin E regulation of the immune response. Immunol Today 1991;12:349-352.
30. Mills CD: Molecular basis of suppressor macrophages. J Immunol 1991;146:2719-2723.
31. Sileghem M, Darji M, Remels L, Hamers R, De Baetselier P: Different mechanisms account for the suppression of interleukin-2 production and the suppression of interleukin-2 receptor expression in Trypanosoma brucei-infected mice. Eur J Immunol 1989;19:119-124.
32. Mabbott NA, Sutherland IA, Sternberg JM: Suppressor macrophages in Trypanosoma brucei infection: Nitric oxide is related to both suppressive activity and lifespan in vivo. Parasite Immunol 1995;17:143-150.
33. Sternberg JM, Mabbott NA, Sutherland IA, Liew FY: Inhibition of nitric oxide synthesis leads to reduced parasitemia in murine Trypanosoma brucei infection. Infect Immun 1994;62:2135-2137.
34. Mabbott NA, Sternberg JM: Bone-marrow nitric oxide production and the development of anemia in Trypanosoma brucei-infected mice. Infect Immun 1995;63:1563-1566.
35. Sternberg JM: Elevated serum nitrate in Trypanosoma brucei rhodesiense infections: Evidence for inducible nitric oxide synthesis in trypanosomiasis. Trans R Soc Trop Med Hyg 1996;90:395.
36. Albina JE: On the expression of inducible nitric oxide synthase by human macrophages: Why no NO? J Leukoc Biol 1995;58:643-649.
37. Vincendeau P, Daulouede S, Vegret B, Darde ML, Bouteille B, Lemesre JL: Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and T. b. brucei. Exp Parasitol 1992;75:353-360.
38. Mabbott NA, Sutherland IA, Sternberg JM: Trypanosoma brucei is protected from the cytostatic effects of nitric oxide under in vivo conditions. Parasitol Res 1994;80:687-690.
39. Beutler B, Cerami A: The biology of cachectin/TNF: A primary mediator of the host response. Annu Rev Immunol 1989;7:625-655.
40. Magez S, Lucas R, Darji A, Songa EB, Hamers R, De Baetselier P: Murine tumour necrosis factor plays a protective role during the initial phase of the experimental infection with Trypanosoma brucei brucei. Parasite Immunol 1993;15:635-641.
41. Lucas R, Magez S, De Leys R: Mapping the lectin-like activity of tumour necrosis factor. Science 1994;263:814-817.
42. Bonfanti C, Caruso A, Bakhiet M, Olsson T, Turano A, Kristensson K: Increased levels of antibodies to IFN-γ in human and experimental African trypanosomiasis. Scand J Immunol 1995;41:49-52.
43. Bancroft GJ, Sutton AG, Morris AJ, Askonas BA: Production of interferons during experimental African trypanosomiasis. Clin Exp Immunol 1983;52:135-143.
44. + T cells suppresses growth of Trypanosoma brucei brucei and interferon-gamma production in infected rats. Clin Exp Immunol 1990;81:195-199.
45. Olsson T, Bakhiet M, Hojeberg B, Ljungdahl A, Edlund C, Anderson G, Ekre H, Fung-Leung W, Mak T, Wigzell H, Fiszer U, Kristensson K: CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell 1993;72:715-727.
46. Schleifer KW, Filutowicz H, Schopf LR, Mansfield JM: Characterisation of T helper cell responses to the trypanosome variant surface glycoprotein. J Immunol 1993;150:2910-2919.
47. + T cells: A trypanosome-released factor triggers interferon-γ production that stimulates parasite growth. Eur J Immunol 1991;21:2447-2454.
48. + lymphocytes to interferon-γ secretion: Purification, characterisation and protective effects in vivo by treatment with a monoclonal antibody against the factor. Scand J Immunol 1993;37:165-178.
49. Jones JF, Hancock GE: Trypanosomiasis in mice with naturally occurring immunodeficiencies. Infect Immun 1983;42:848-851.
50. Bakhiet M, Olsson T, Mhlanga J, Buscher P, Lycke N, Van der Meide P, Kristensson K: Human and rodent interferon-gamma as a growth factor for Trypanosoma brucei. Eur J Immunol 1996;26: 1359-1364.
51. Sternberg JM, McGuigan F: Trypanosoma brucei: Mammalian epidermal growth factor promotes the growth of the African trypanosome bloodstream form. Exp Patasitol 1994;78:422-424.
52. Hide G, Gray A, Harrisson CM, Tait A: Identification of an epidermal growth factor receptor homologue in African trypanosomes. Mol Biochem Parasitol 1989;36:51-60.
53. Grosskinsky CM, Askonas BA: Macrophages as primary target cells and mediators of immune dysfunction in African trypanosomiasis. Infect Immun 1981;33:149-155.
54. Sacks DL, Bancroft G, Evans WH, Askonas BA: Incubation of trypanosome-derived mitogenic and immunosuppressive products with peritoneal macrophages allows recovery of biological activities from soluble parasite fractions. Infect Immun 1982;36:160-168.
55. Diffley P: Trypanosomal surface coat antigen causes polyclonal lymphocyte activation. J Immunol 1983;131:1983-1986.
56. Oka M, Yabu Y, Ito Y, Takayanagi T: Polyclonal B-cell simulative and immunosuppressive activities at different developmental stages of Trypanosoma brucei gambiense. Microbiol Immunol 1988;32: 1175-1177.
57. Darji A, Beschin A, Sileghem M, Heremans H, Brys L, DeBaetselier P: In vitro simulation of immunosuppression caused by Trypanosoma brucei: Active involvement of gamma Interferon and tumor necrosis factor in the pathway of suppression. Infect Immun 1996;64:1937-1943.
58. Sternberg J, Mabbott N: Nitric oxide-mediated suppression of T-cell responses during Trypanosoma brucei infection: Soluble trypanosome products and interferon-γ are synergistic inducers of nitric oxide synthase. Eur J Immunol 1996;26:539-543.
59. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TW, Taniguchi T, Vilcek J: Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994;263:1612-1615.
60. Isobe K-I, Nakashima I: Feedback suppression of staphylococcal enterotoxin-stimulated T-lymphocyte proliferation by macrophages through inductive nitric oxide synthesis. Infect Immun 1992;60: 4832-4837.
61. Cunha FQ, Moss DW, Leal LMCC, Moncada S, Liew FY: Induction of macrophage parasiticidal activity by Staphylococcus aureus and exotoxins through the nitric oxide synthesis pathway. Immunology 1993;78:563-567.
62. Cunha FQ, Assreuy J, Moncada S, Liew FY: Phagocytosis and induction of nitric oxide synthase in murine macrophages. Immunology 1993;79:408-411.
63. Mansfield JM: Immunology and immunopathology of African trypanosomiasis; in Mansfield JM (ed): Parasitic Diseases. New York, Dekker, 1981, vol 1, pp 167-226.
64. Bulow R, Nonnengasser C, Overath P: Release of the variant specific glycoprotein during differentiation of bloodstream to procyclic forms of Trypanosoma brucei. Mol Biochem Parasitol 1989;32: 85-92.
65. Milon G, Del Giudice G, Louis JA: Immunobiology of experimental cutaneous Leishmaniaisis. Parasitol Today 1995;11:244-247.
66. Rottenburg ME, Castanos-Velez E, DeMesquita R, Laguardia OG, Biberfeld P, Orn A: Intracellular colocalisation of Trypanosoma cruzi and inducible nitric synthase. Eur J Immunol 1996;26:3203-3213.
67. Kierszenbaum F, Muthukkumar S, Beltz LA, Sztein MB: Suppression by Trypanosoma brucei rhodesiense of the capacities of human T-lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation. Infect Immun 1991;59:3518-3522.